IALURIL Prefill - Bladder instillation, barrier

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Available from:

Juno Pharmaceuticals Pty Ltd

Class:

Class III

Manufactured by:

IBSA Farmaceutici Italia Srl Via Martiri di Cefalonia 2, Lodi, 26900 Italy

Therapeutic area:

44670 - Bladder instillation, barrier

Therapeutic indications:

Clear plastic pre-filled syringe containing a sterile aqueous solution of hyaluronic acid sodium salt (1.6%), sodium chondroitin sulphate (2%) and calcium chloride administered as a bladder instillation via a catheter. iAluRil Prefill is indicated to re-establish the glycosaminoglycan layers (GAGs) of the urothelial vesical tissue in cases in which their loss can cause frequent and recurring problems such as Painful Bladder Syndrome (PBS), interstitial cystitis, treatment and prevention of recurrent urinary tract infection, cystitis as a result of Bacillus Calmette ? Guerin therapy, or chemical and radiation therapy. iAluRil Prefill is also indicated in the cases where the loss of the glycosaminoglycan layers (GAGs) is associated with forms of chronic inflammation, in which their composition and integrity appears compromised in different ways.

Authorization status:

A

Authorization date:

2014-11-07